Alexis Retractor in Total Hip Arthroplasty
Starting soon · Not applicable
Conditions studied: Hip Osteoarthritis, Hip Arthritis
In brief
To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
Key facts
- Study ID
- NCT07237737
- Run by
- University of Miami
- People needed
- 202
- Starts
- 2026-12-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty
- Patients undergoing primary total hip arthroplasty
You may not qualify if…
- Patients with history of prior open surgery on the affected hip
- Patients with history of prior total hip arthroplasty on the contralateral hip
- Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
Where it is running
- University of Miami — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.